Objective. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as
a useful alternative intervention to redo-surgical aortic valve replacement (Redo-SVAR) for …

Aims To evaluate all-cause mortality in ViV-TAVI versus redo SAVR in patients with failed
bioprostheses. Methods Study-level meta-analysis of reconstructed time-to-event data from …

Valve-in-valve (ViV) transcatheter aortic valve implantation (ViV-TAVI) in patients with failed
bioprostheses arose as an alternative to redo surgical aortic valve replacement (SAVR). To …

Introduction Postoperative acute kidney injury (AKI) and the requirement for renal
replacement therapy (RRT) remain common and significant complications of both …

Transcatheter aortic valve implantation (TAVI) is now a commonly used therapy in patients
with severe aortic stenosis, even in those patients at low surgical risk. The indications for …

Background This study focuses on a quality improvement (QI) project initiated in April 2019,
aimed at reducing redo rates in pulmonary vein isolation (PVI) procedures. Methods The …

The need for a permanent pacemaker (PPM) implantation after surgical aortic valve
implantation (SAVR) is a recognized postoperative complication, with potentially long-term …

Aortic stenosis is a common and significant valve condition requiring bioprosthetic heart
valves (BHV) with transcatheter aortic valve replacement (TAVR) being strongly …

抄録 挙児希望の弁膜症患者に対しては, ワルファリン服用が不要になるよう生体弁の使用,
もしくは弁形成を選択する必要があり, 将来的に再手術が必要となってくることがある …